BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2137792)

  • 1. Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients.
    Zorn JR; Mathieson J; Risquez F; Comaru-Schally AM; Schally AV
    Fertil Steril; 1990 Mar; 53(3):401-6. PubMed ID: 2137792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
    Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC
    Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical reversible castration with D-Trp-6-LH-RH microcapsules for the treatment of endometriosis. Preliminary results in a series of 51 patients.
    Zorn JR; Soubrane O; Siboni O; Papageorgiou G
    Contrib Gynecol Obstet; 1987; 16():254-9. PubMed ID: 2961507
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis.
    Zorn JR; Tanger C; Roger M; Grenier J; Comaru-Schally AM; Schally AV
    Int J Fertil; 1986; 31(1):11-3, 16-27. PubMed ID: 2908272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monthly administration of the LH-RH analogue decapeptyl for long-term treatment of ovarian dysfunctions and estrogen-dependent disorders.
    Geisthoevel F; Hils K; Wieacker P; Breckwoldt M; Schultheiss H
    Int J Fertil; 1989; 34(4):262-70. PubMed ID: 2570764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.
    Redding TW; Schally AV; Tice TR; Meyers WE
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5845-8. PubMed ID: 6237365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.
    Schally AV; Kook AI; Monje E; Redding TW; Paz-Bouza JI
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8764-8. PubMed ID: 2946045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2498-502. PubMed ID: 3157990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH2(10)]LH-RH ethylamide.
    Dupont A; Dupont P; Belanger A; Mailoux J; Cusan L; Labrie F
    Fertil Steril; 1990 Aug; 54(2):227-32. PubMed ID: 2199228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats.
    Bokser L; Szende B; Schally AV
    Br J Cancer; 1990 Jun; 61(6):861-5. PubMed ID: 2142603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
    Olivennes F; Belaisch-Allart J; Emperaire JC; Dechaud H; Alvarez S; Moreau L; Nicollet B; Zorn JR; Bouchard P; Frydman R
    Fertil Steril; 2000 Feb; 73(2):314-20. PubMed ID: 10685535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.
    Okada H; Heya T; Ogawa Y; Shimamoto T
    J Pharmacol Exp Ther; 1988 Feb; 244(2):744-50. PubMed ID: 3126294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of endometriosis with domestic luteinizing hormone--releasing hormone analogue].
    Geng L; Gu FY; Zhang LZ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):592-4, 636. PubMed ID: 7712871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of D-Trp6-luteinizing hormone-releasing hormone on testicular size and luteinizing hormone, follicle-stimulating hormone, and testosterone levels in hypothalamic hypogonadotropic males.
    Laron Z; Dickerman Z; Ben Zeev Z; Prager-Lewin R; Comaru-Schally AM; Schally AV
    Fertil Steril; 1981 Mar; 35(3):328-31. PubMed ID: 6781940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.
    Lemay A; Quesnel G
    Fertil Steril; 1982 Sep; 38(3):376-9. PubMed ID: 6214431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations.
    Mason-Garcia M; Vigh S; Comaru-Schally AM; Redding TW; Somogyvari-Vigh A; Horvath J; Schally AV
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1547-51. PubMed ID: 3156381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
    Perl V; Marquez J; Schally AV; Comaru-Schally AM; Leal G; Zacharias S; Gomez-Lira C
    Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.
    Meldrum DR; Chang RJ; Lu J; Vale W; Rivier J; Judd HL
    J Clin Endocrinol Metab; 1982 May; 54(5):1081-3. PubMed ID: 6801075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.